{"nct_id":"NCT02474069","title":"Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis","status":"COMPLETED","status_verified_date":"2019-04","start_date":"2015-02-08","start_date_type":"ACTUAL","primary_completion_date":"2016-09-15","primary_completion_date_type":"ACTUAL","completion_date":"2016-09-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}